24.01
price up icon1.24%   0.29
 
loading
전일 마감가:
$23.72
열려 있는:
$23.51
하루 거래량:
335.15K
Relative Volume:
0.64
시가총액:
$1.67B
수익:
$133.62M
순이익/손실:
$-177.37M
주가수익비율:
-11.22
EPS:
-2.14
순현금흐름:
$23.50M
1주 성능:
+2.19%
1개월 성능:
+13.92%
6개월 성능:
+1.03%
1년 성능:
+29.81%
1일 변동 폭
Value
$23.50
$24.20
1주일 범위
Value
$22.60
$24.20
52주 변동 폭
Value
$15.31
$26.84

Xencor Inc Stock (XNCR) Company Profile

Name
명칭
Xencor Inc
Name
전화
626-305-5900
Name
주소
465 N. HALSTEAD ST., PASADENA, CA
Name
직원
280
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
XNCR's Discussions on Twitter

XNCR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
XNCR 24.01 1.67B 133.62M -177.37M 23.50M -2.14
VRTX 450.00 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.66 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 588.46 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 248.13 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.53 24.89B 3.30B -501.07M 1.03B 11.54

Xencor Inc Stock (XNCR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-16 재확인 BTIG Research Buy
2024-02-28 다운그레이드 Piper Sandler Overweight → Neutral
2023-05-19 개시 BofA Securities Buy
2022-12-06 개시 Cowen Outperform
2022-10-13 업그레이드 Raymond James Outperform → Strong Buy
2022-09-21 개시 JP Morgan Overweight
2022-07-06 재개 Canaccord Genuity Buy
2022-02-11 개시 BMO Capital Markets Outperform
2022-01-21 개시 SMBC Nikko Outperform
2021-12-15 개시 H.C. Wainwright Buy
2021-10-15 재개 BTIG Research Buy
2021-02-24 업그레이드 Raymond James Mkt Perform → Outperform
2020-03-04 개시 Barclays Underweight
2020-02-25 업그레이드 Guggenheim Neutral → Buy
2020-01-30 개시 RBC Capital Mkts Outperform
2019-11-20 재개 Guggenheim Neutral
2019-08-07 다운그레이드 Guggenheim Buy → Neutral
2019-08-07 다운그레이드 Raymond James Outperform → Mkt Perform
2019-06-13 개시 Mizuho Buy
2019-04-12 개시 Guggenheim Buy
2019-03-27 개시 Berenberg Buy
2019-03-15 개시 Raymond James Outperform
2018-09-10 재개 BTIG Research Buy
2018-03-28 재개 Leerink Partners Outperform
2017-03-02 개시 Instinet Neutral
2017-03-02 재확인 Wedbush Outperform
2016-10-04 개시 Piper Jaffray Overweight
2015-12-22 개시 Canaccord Genuity Buy
2015-08-05 재확인 MLV & Co Buy
2015-02-12 재확인 Oppenheimer Outperform
2015-01-28 재확인 MLV & Co Buy
2014-07-11 개시 Oppenheimer Outperform
모두보기

Xencor Inc 주식(XNCR)의 최신 뉴스

pulisher
09:26 AM

Principal Financial Group Inc. Sells 15,251 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

09:26 AM
pulisher
Nov 20, 2024

Xencor Reports Q3 2024 Earnings and Program Updates - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 20, 2024
pulisher
Nov 16, 2024

(XNCR) Proactive Strategies - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 15, 2024

EcoR1 Capital, LLC Increases Stake in Xencor Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Xencor CEO Dahiyat Bassil sells shares worth $80,841 - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Xencor executive sells shares worth $1.6 million By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Xencor executive sells shares worth $1.6 million - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

PRIMECAP Management Bolsters Stake in Xencor Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Xencor's SWOT analysis: biotech stock faces pivotal year ahead - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Xencor's SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14% - Yahoo Finance UK

Nov 12, 2024
pulisher
Nov 11, 2024

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Creative Planning - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor’s (XNCR) “Outperform” Rating Reiterated at BMO Capital Markets - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor (NASDAQ:XNCR) Given New $28.00 Price Target at JPMorgan Chase & Co. - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor (NASDAQ:XNCR) Given Outperform Rating at Wedbush - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush’s Forecast for Xencor FY2024 Earnings? - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Increases Earnings Estimates for Xencor - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Brokers Lift Earnings Estimates for Xencor - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush's Forecast for Xencor FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Xencor, Inc. (NASDAQ:XNCR) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Nov 10, 2024
pulisher
Nov 08, 2024

Xencor (NASDAQ:XNCR) Receives "Outperform" Rating from BMO Capital Markets - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Xencor shares target raised, rating held on pipeline progress By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Xencor shares target raised, rating held on pipeline progress - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor (NASDAQ:XNCR) shareholders are up 7.9% this past week, but still in the red over the last three years - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor Reports Third Quarter 2024 Financial Results - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Xencor Inc earnings beat by $0.27, revenue fell short of estimates - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Xencor: Q3 Earnings Snapshot - San Antonio Express-News

Nov 06, 2024
pulisher
Nov 05, 2024

Trading (XNCR) With Integrated Risk Controls - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 04, 2024

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - BioSpace

Nov 04, 2024
pulisher
Nov 04, 2024

Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor - IPWatchdog.com

Nov 04, 2024
pulisher
Nov 04, 2024

942 in Development for Patients with Inflammatory Bowel Disease - Business Wire

Nov 04, 2024
pulisher
Nov 01, 2024

Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? - Yahoo Finance

Nov 01, 2024
pulisher
Oct 29, 2024

Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? - MSN

Oct 29, 2024
pulisher
Oct 26, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat

Oct 26, 2024
pulisher
Oct 26, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts - Defense World

Oct 26, 2024

Xencor Inc (XNCR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):